New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
RNA regulation is crucial for embryonic stem cell differentiation

RNA regulation is crucial for embryonic stem cell differentiation

by Lisbeth Heilesen,Aarhus UniversityA functional link between nuclear RNA decay and transcriptional control by the Polycomb Repressive Complex 2. In the absence of PAXT-mediated RNA decay, nucl
World medicine November 30,2023
RNA regulation is crucial for embryonic stem cell differentiation

RNA regulation is crucial for embryonic stem cell differentiation

by Lisbeth Heilesen,Aarhus UniversityA functional link between nuclear RNA decay and transcriptional control by the Polycomb Repressive Complex 2. In the absence of PAXT-mediated RNA decay, nucl
World medicine November 30,2023
New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

byThe Wistar InstituteCredit: CC0 Public DomainThe Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells thro
World medicine November 30,2023
New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

byThe Wistar InstituteCredit: CC0 Public DomainThe Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells thro
World medicine November 30,2023
RNA discoveries could improve stem cell research

RNA discoveries could improve stem cell research

by Will Doss,Northwestern UniversityA hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single strand of RNA tha
World medicine November 30,2023
RNA discoveries could improve stem cell research

RNA discoveries could improve stem cell research

by Will Doss,Northwestern UniversityA hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single strand of RNA tha
World medicine November 30,2023
How to reduce your risk of gynecological cancer

How to reduce your risk of gynecological cancer

by Chad A. Hamilton, Ochsner HealthCredit: Pixabay/CC0 Public DomainThe American Cancer Society estimates about 115,000 women will be diagnosed with a gynecologic cancer this year. That's one case
World medicine November 30,2023
How to reduce your risk of gynecological cancer

How to reduce your risk of gynecological cancer

by Chad A. Hamilton, Ochsner HealthCredit: Pixabay/CC0 Public DomainThe American Cancer Society estimates about 115,000 women will be diagnosed with a gynecologic cancer this year. That's one case
World medicine November 30,2023
Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer

Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer

byKanazawa UniversityEffects of gene mutations on tumor development. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-23-1490Researchers at Kanazawa University report in&nbsp
World medicine November 30,2023
Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer

Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer

byKanazawa UniversityEffects of gene mutations on tumor development. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-23-1490Researchers at Kanazawa University report in&nbsp
World medicine November 30,2023
Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer

Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer

by Elana GotkineFor patients with HER2-positive gastroesophageal junction (GEJ) adenocarcinoma, pembrolizumab improves progression-free survival when combined with chemotherapy and trastuzumab, accord
World medicine November 30,2023
Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer

Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer

by Elana GotkineFor patients with HER2-positive gastroesophageal junction (GEJ) adenocarcinoma, pembrolizumab improves progression-free survival when combined with chemotherapy and trastuzumab, accord
World medicine November 30,2023
Caveolin binding motif in Na/K-ATPase is required for stem cell differentiation, organogenesis in animals

Caveolin binding motif in Na/K-ATPase is required for stem cell differentiation, organogenesis in animals

by Marshall UniversityCaenorhabditis elegans. Credit: WikipediaNew findings reveal the importance of the Na/K-ATPase protein in stem cell differentiation and organogenesis, in a study led by scientist
World medicine November 30,2023
Caveolin binding motif in Na/K-ATPase is required for stem cell differentiation, organogenesis in animals

Caveolin binding motif in Na/K-ATPase is required for stem cell differentiation, organogenesis in animals

by Marshall UniversityCaenorhabditis elegans. Credit: WikipediaNew findings reveal the importance of the Na/K-ATPase protein in stem cell differentiation and organogenesis, in a study led by scientist
World medicine November 30,2023
Study shows no increase in cancer risk for most patients with reflux disease

Study shows no increase in cancer risk for most patients with reflux disease

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainReflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer. However, a new study publis
World medicine November 30,2023
Study shows no increase in cancer risk for most patients with reflux disease

Study shows no increase in cancer risk for most patients with reflux disease

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainReflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer. However, a new study publis
World medicine November 30,2023
Micro-RNAs keep stem cells from growing up too fast

Micro-RNAs keep stem cells from growing up too fast

by Kim Krieger,University of ConnecticutMicro-RNAs (µRNAs) act like a series of obstacles a young cell must hurdle before it can reach its mature form. Credit: UConn illustration/Yesenia Carrero
World medicine November 30,2023
Micro-RNAs keep stem cells from growing up too fast

Micro-RNAs keep stem cells from growing up too fast

by Kim Krieger,University of ConnecticutMicro-RNAs (µRNAs) act like a series of obstacles a young cell must hurdle before it can reach its mature form. Credit: UConn illustration/Yesenia Carrero
World medicine November 30,2023
DNA damage triggers reprogramming into stem cells

DNA damage triggers reprogramming into stem cells

by National Institutes of Natural SciencesDNA damage causes cells to reprogram themselves into stem cells and regenerate new plant bodies in the moss Physcomitrella patens. Credit: NIBBA joint researc
World medicine November 30,2023
DNA damage triggers reprogramming into stem cells

DNA damage triggers reprogramming into stem cells

by National Institutes of Natural SciencesDNA damage causes cells to reprogram themselves into stem cells and regenerate new plant bodies in the moss Physcomitrella patens. Credit: NIBBA joint researc
World medicine November 30,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com